Prognostic impact of proliferation-associated factors MIBI (Ki-67) and S-phase in node-negative breast cancer
1997

Prognostic Impact of Proliferation Factors in Node-Negative Breast Cancer

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): P Dettmar, N Harbeck, C Thomssen, L Pache, P Ziffer, K Fizi, F Janicke, W Nathrath, M Schmitt, H Graeff, H Hofler

Primary Institution: Technische Universitat Munchen

Hypothesis

Can MIB1 proliferation rate and total S-phase fraction serve as significant prognostic factors in node-negative breast cancer?

Conclusion

MIB1 proliferation rate and total S-phase fraction provide additional prognostic information in node-negative breast cancer, with total S-phase fraction being the stronger predictor.

Supporting Evidence

  • MIB1-PR was significantly correlated to grading (P = 0.018).
  • SPF was significantly correlated with tumour size (P = 0.041) and inversely with steroid hormone receptor status (P = 0.030).
  • In univariate analysis, both MIB1-PR and SPF were significant prognostic factors for disease-free survival (DFS).
  • In multivariate analysis, only SPF remained significant; it was the strongest prognostic factor for DFS (P = 0.0073).

Takeaway

This study looked at how fast cancer cells grow in patients with breast cancer that hasn't spread to the lymph nodes, finding that some tests can help predict how well patients will do after treatment.

Methodology

The study analyzed formalin-fixed, paraffin-embedded sections from 90 primary node-negative breast carcinomas, assessing MIB1 proliferation rate and total S-phase fraction.

Limitations

The study only included patients who did not receive adjuvant systemic therapy, which may limit the generalizability of the findings.

Participant Demographics

The study included 90 patients with primary node-negative breast cancer, with a median follow-up of 37.5 months.

Statistical Information

P-Value

P = 0.0073 for SPF in multivariate analysis

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication